News about Global Pharma

aTyr Pharma Welcomes Dalia R. Rayes as Head of Commercial-Global Efzofitimod Franchise

Rayes brings over 25 years of experience building and leading commercial organizations at biotechnology and pharmaceutical companies, including leading rare disease product launches.

Global Pharma | 27/03/2025 | By Aishwarya |  648

Department of Pharmaceuticals Organises Industry Dialogue on PRIP Scheme in Bengaluru

The session provided detailed insights into the PRIP Scheme, along with other government initiatives promoting and enabling research innovation in the sector.

Global Pharma | 27/03/2025 | By Aishwarya |  326

Rarecells Appoints Dr. Neil Kurtz to its Board of Directors

Rarecells Inc. announces the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of experience in the pharmaceutical, contract research, post-acute care, and medical diagnostic sectors.

Global Pharma | 26/03/2025 | By Manvi |  252

CDSCO Launches Digital Portal to Simplify Extension Process for Pharma MSMEs

This initiative is integrated into the Online National Drugs Licensing System (ONDLS) and follows the Health Ministry's notification granting an extension for compliance with updated Good Manufacturing Practices (GMP).

Global Pharma | 26/03/2025 | By Aishwarya |  470

Sense Diagnostics Appoints Gary Kurdziel as Chief Executive Officer, Effective from April 1, 2025

Sense Diagnostics, Inc. announced that its board of directors has appointed Gary Kurdziel as Chief Executive Officer, effective April 1, 2025. Kurdziel, who most recently served as EVP and CCO for Sense Neuro Diagnostics, brings extensive global leadership experience spanning more than three decades in the medical device industry.

Global Pharma | 25/03/2025 | By Manvi |  268

Oxford BioTherapeutics and Roche to Research on Novel Targets for Antibody-Based Therapeutics

OBT’s recently launched enhanced proprietary OGAP®-Verify discovery platform enables greater sensitivity and thereby the selection of targets with improved attributes for drug development.

Global Pharma | 25/03/2025 | By Aishwarya |  238

Syngene International to Procure Renewable Energy from O2 Power

Syngene International Ltd., a Biocon subsidiary, will procure renewable energy from O2 Power’s 201.2 MW wind-solar hybrid plant in Karnataka under a captive arrangement. The company acquired 33.79 percent stake in the SPV for INR 6.5 crore.

Global Pharma | 25/03/2025 | By Manvi |  401

Wheeler Bio Plans for Expansion with Closing of Oversubscribed Series A-1 Financing Round

The USD 35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises.

Global Pharma | 25/03/2025 | By Aishwarya |  283

Chang Gung Memorial Hospital Leads Taiwan with 12,000+ Robotic Surgeries

By the end of 2024, the hospital had performed over 12,000 robotic surgeries, accounting for one-sixth of Taiwan's robotic procedures and cementing its leadership in the field. With its technical expertise and clinical achievements, Chang Gung is steering Taiwan into a new era of minimally invasive surgery worldwide with its robust healthcare system.

Global Pharma | 24/03/2025 | By Manvi |  215

SMS Pharma Announces Successful Completion of USFDA Inspection at Hyderabad API Facility

SMS Pharmaceuticals has successfully completed a USFDA inspection at its Bachupally API facility in Hyderabad, receiving one procedural observation with no impact on data integrity or product quality.

Global Pharma | 24/03/2025 | By Manvi |  529